Oyster Point Pharma, Inc.
SEC CIK 1720725 · OYST · last insider filing 2023-01-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lainovic Sacha | Director | filed 2019 - 2023 |
| Invopps IV US, L.P. | Director | filed 2019 - 2023 |
| Invopps GP IV, L.L.C. | Director | filed 2019 - 2023 |
| Invopps IV, L.P. | Director | filed 2019 - 2023 |
| Atieh Michael G | Director | filed 2020 - 2023 |
| Weisner Aimee S | Director | filed 2019 - 2023 |
| Santel Donald J | Director | filed 2021 - 2023 |
| Behbahani Ali | Director | filed 2019 - 2023 |
| Ozawa Clare | Director | filed 2019 - 2023 |
| Nau Jeffrey | Director · President and CEO | filed 2019 - 2023 |
| Tsai Benjamin | Director | filed 2019 - 2023 |
| Murray Mark Anthony | Director | filed 2019 - 2023 |
| Eliades George Christopher | Director | filed 2021 - 2023 |
| Link William J PHD | Director | filed 2019 - 2022 |
| Ackermann Michael | Director | filed 2019 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lochner Daniel | Chief Financial Officer | filed 2019 - 2023 |
| Snisarenko John | Chief Commercial Officer | filed 2019 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.